NCT04150042 2026-01-29
SHARON
General Oncology, Inc.
Phase 1 Recruiting
Clinical Trials
4 trialsNCT02206425 2023-10-31
Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients
Oncotherapeutics
Phase 1/2 Completed
NCT05932511 2023-08-30
Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Unknown
NCT04279535 2021-11-02
Topical Vitamin C for Treatment of Basal Cell Cancer
Center for Biomedical Research, Inc.
Phase EARLY_PHASE1 Completed